JP2024527142A5 - - Google Patents

Info

Publication number
JP2024527142A5
JP2024527142A5 JP2024506585A JP2024506585A JP2024527142A5 JP 2024527142 A5 JP2024527142 A5 JP 2024527142A5 JP 2024506585 A JP2024506585 A JP 2024506585A JP 2024506585 A JP2024506585 A JP 2024506585A JP 2024527142 A5 JP2024527142 A5 JP 2024527142A5
Authority
JP
Japan
Prior art keywords
mutation
dna
group
tumor
length threshold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024506585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527142A (ja
Filing date
Publication date
Priority claimed from EP21189685.7A external-priority patent/EP4130293A1/en
Application filed filed Critical
Publication of JP2024527142A publication Critical patent/JP2024527142A/ja
Publication of JP2024527142A5 publication Critical patent/JP2024527142A5/ja
Pending legal-status Critical Current

Links

JP2024506585A 2021-08-04 2022-08-02 リキッドバイオプシーにおける変異検出の方法 Pending JP2024527142A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21189685.7 2021-08-04
EP21189685.7A EP4130293A1 (en) 2021-08-04 2021-08-04 Method of mutation detection in a liquid biopsy
PCT/EP2022/071749 WO2023012186A1 (en) 2021-08-04 2022-08-02 Method of mutation detection in a liquid biopsy

Publications (2)

Publication Number Publication Date
JP2024527142A JP2024527142A (ja) 2024-07-19
JP2024527142A5 true JP2024527142A5 (cg-RX-API-DMAC7.html) 2025-08-06

Family

ID=77226600

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024506585A Pending JP2024527142A (ja) 2021-08-04 2022-08-02 リキッドバイオプシーにおける変異検出の方法

Country Status (4)

Country Link
US (1) US20240327924A1 (cg-RX-API-DMAC7.html)
EP (2) EP4130293A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024527142A (cg-RX-API-DMAC7.html)
WO (1) WO2023012186A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120048346B (zh) * 2025-01-24 2026-02-27 中科金辰生物科技(合肥)有限公司 一种肿瘤特异性基因突变和甲基化联合生物信息学分析方法及系统

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11342047B2 (en) * 2017-04-21 2022-05-24 Illumina, Inc. Using cell-free DNA fragment size to detect tumor-associated variant
GB201819134D0 (en) * 2018-11-23 2019-01-09 Cancer Research Tech Ltd Improvements in variant detection
GB201818159D0 (en) 2018-11-07 2018-12-19 Cancer Research Tech Ltd Enhanced detection of target dna by fragment size analysis
WO2020186024A1 (en) * 2019-03-13 2020-09-17 Grail, Inc. Systems and methods for enriching for cancer-derived fragments using fragment size

Similar Documents

Publication Publication Date Title
Addeo et al. TMB or not TMB as a biomarker: That is the question
KR102930361B1 (ko) 암의 평가 및/또는 치료를 위한 무 세포 dna
CN114736968B (zh) 血浆游离dna甲基化标志物在肺癌早筛中的用途以及肺癌早筛装置
CN110689921B (zh) 微卫星不稳定性检测装置、计算机设备及计算机存储介质
RU2760577C2 (ru) Способы прогнозирования рака предстательной железы
JP7634714B2 (ja) 人工知能基盤の無細胞DNAの腫瘍由来変異の検出方法及びこれを用いたがんの早期診断方法{Method for detecting tumor derived mutation from cell-free DNA based on artificial intelligence and Method for early diagnosis of cancer using the same}
JP2021503149A (ja) がん治療の有効性を予測するためのシステムおよび方法
TWI670495B (zh) 一種鑑定樣本中腫瘤負荷的方法和系統
JP2023508947A5 (cg-RX-API-DMAC7.html)
WO2015035415A1 (en) Method of detecting suceptibility to breast cancer through mutations in the fgfr3 and tp53 genes
JP2023082157A (ja) 遺伝子調節
JP2021523744A (ja) 脳卒中の血液バイオマーカー
CN111899789A (zh) 二代测序鉴定brca1/2大片段重排的方法及系统
CN119776488A (zh) 一种心力衰竭的生物标志物及其应用
KR20170067137A (ko) 암 진단용 miRNA 바이오마커 발굴 방법 및 그 이용
JP2024527142A5 (cg-RX-API-DMAC7.html)
CN116762132A (zh) 基于游离dna的疾病预测模型及其构建方法和应用
CN111172285A (zh) 用于胰腺癌早期诊断和/或预后监测的miRNA组及其应用
CN103911439A (zh) 系统性红斑狼疮羟甲基化状态的差异表达基因的分析方法和应用
KR20240015624A (ko) 게놈 전체 cfdna 단편화 프로파일을 이용한 암을 검출하는 방법
CN110004229A (zh) 多基因作为egfr单克隆抗体类药物耐药标志物的应用
JP2024504062A (ja) 染色体相互作用
JP6784673B2 (ja) 膵臓がんに冒された患者の生存予後を判断する方法
US20190352704A1 (en) Benign thyroid nodule-specific gene
WO2025019254A1 (en) Classification of breast tumors using dna methylation from liquid biopsy